Physician profile
Catherine Cunningham
NPI 1760458244
$771.54
in general payments reported to CMS, 2019-2025
13 companies · $47.86 in 2025
The $47.86 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $46.87 · 2021: $62.79 · 2022: $153 · 2023: $81.27 · 2024: $276 · 2025: $47.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.52 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $142.58 | 2020-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $139.79 | 2019-2021 | |
| Madrigal Pharmaceuticals | $113.51 | 2024 | Rezdiffra |
| Astellas Pharma US INC | $104.17 | 2022 | |
| Boston Scientific Corporation | $77.07 | 2024 | Watchman Flx |
| Grifols USA, LLC | $37.06 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.23 | 2020 | |
| Abiomed | $25.94 | 2023 | Impella |
| Reprise Biomedical, INC. | $25.30 | 2025 | Miro3d |
| Janssen Pharmaceuticals, INC | $24.43 | 2019-2022 | |
| Csl Behring | $20.00 | 2023 | Kcentra |
| Irhythm Technologies, INC. | $16.76 | 2023 | Zio Xt Patch |
| Amarin Pharma, INC. | $13.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.